Thrivent Financial for Lutherans’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9K | Buy |
+10,000
| New | +$9K | ﹤0.01% | 2424 |
|
|
2025
Q1 | – | Sell |
-10,000
| Closed | -$5K | – | 2473 |
|
|
2024
Q4 | $5K | Buy |
+10,000
| New | +$5K | ﹤0.01% | 2547 |
|
|
2024
Q2 | – | Sell |
-15,000
| Closed | -$22K | – | 2557 |
|
|
2024
Q1 | $22K | Hold |
15,000
| – | – | ﹤0.01% | 2501 |
|
|
2023
Q4 | $16K | Hold |
15,000
| – | – | ﹤0.01% | 2475 |
|
|
2023
Q3 | $18K | Hold |
15,000
| – | – | ﹤0.01% | 2423 |
|
|
2023
Q2 | $21K | Hold |
15,000
| – | – | ﹤0.01% | 2450 |
|
|
2023
Q1 | $22K | Hold |
15,000
| – | – | ﹤0.01% | 2429 |
|
|
2022
Q4 | $18K | Hold |
15,000
| – | – | ﹤0.01% | 2402 |
|
|
2022
Q3 | $17K | Buy |
+15,000
| New | +$17K | ﹤0.01% | 2398 |
|
|
2021
Q4 | – | Sell |
-42,533
| Closed | -$107K | – | 2497 |
|
|
2021
Q3 | $107K | Sell |
42,533
-137
| -0.3% | -$345 | ﹤0.01% | 2449 |
|
|
2021
Q2 | $121K | Buy |
+42,670
| New | +$121K | ﹤0.01% | 2432 |
|